Skip to content Skip to navigation

Emerging Psychoactive Substances: The History and Pharmacology of “Designer Drugs”

The emergence of “designer drugs” has become a major concern for the addiction and behavioral healthcare communities. These “designer drugs,” better classified as synthetic cannabinoids, synthetic stimulants, hallucinogens, psychedelic-stimulants, and older drug categories trying to make a come-back are making treatment and education very difficult for clinicians and the families of those affected.

In this webinar Lisa Marzilli, PharmD, will discuss current trends and issues surrounding these new and emerging products. Lisa will also identify how efforts to stay current remain a challenge both scientifically and legally. Finally, she will discuss how geography dictates the “flavor-of-the-week” and what substances to be on the lookout for in your area of practice.

Learning Objectives:

  • Identify the key characteristics and effects of synthetic drugs, most notably synthetic cannabinoids, synthetic cathinones and synthetic stimulants
  • Assess strategies for communicating the dangers involved with synthetic drug use
  • Describe the current information on the availability and patterns of synthetic drug use in the United States

CEU Information

The Association for the Addiction Professionals - NAADAC

This course has been approved by Vendome Group, LLC, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider # 993121, Vendome Group LLC is responsible for all aspects of their programming.

NAADAC, the Association for Addiction Professionals, represents the professional interests of more than 85,000 addiction counselors, educators and other addiction-focused health care professionals in the United States, Canada and abroad. NAADAC’s members are addiction counselors, educators and other addiction-focused health care professionals, who specialize in addiction prevention, treatment, recovery support and education. An important part of the healthcare continuum, NAADAC members and its 47 state affiliates work to create healthier individuals, families and communities through prevention, intervention, quality treatment and recovery support.

About the Speaker(s): 

Lisa Marzilli, PharmD, CDOE, RYT
Dominion Diagnostics

Lisa Marzilli holds a Doctorate of Pharmacy Degree and a Bachelor of Science in Pharmacy from the University of Rhode Island, is a diabetes educator, and an adjunct professor at the University of Rhode Island. She has worked in the home infusion/oncology industry and community pharmacy since 1989, focusing primarily on outpatient educational services and wellness programs in disease-state-management.

In 2009, she began working at Dominion Diagnostics, initially focusing on medication monitoring in pain management and addiction recovery, and then continued into clinical research and education. She speaks at many National Symposiums on various topics such as Designer Drugs, Basic Pharmacology/Pharmacokinetics, Neurobiology of Addiction, Mindfulness and Yoga in Addiction Recovery/Behavioral Change, and has been awarded multiple honors and distinctions.

In March 2015, she began working with several Rhode Island physicians and provides medication therapy management (MTM) services to patients, works collaboratively with nurse care managers, physicians, mid-level providers, and office staff as part of the Patient-Centered Medical Home (PCMH) model of care.

She is also a certified yoga teacher (RYT) and began her studies in 2002 at The White Lotus Foundation in Santa Barbara. She has continued her studies in both the philosophy and physical practice of yoga. Lisa teaches weekly classes in Providence and Peacedale, Rhode Island.